Milestone Pharmaceuticals Ownership | Who Owns Milestone Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Milestone Pharmaceuticals Ownership Summary

Milestone Pharmaceuticals is owned by 35.52% institutional investors, 2.48% insiders, and 62.00% retail investors. Blackrock is the largest institutional shareholder, holding 9.91% of MIST shares. Simplify Propel Opportunities ETF is the top mutual fund, with 2.85% of its assets in Milestone Pharmaceuticals shares.

MIST Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Milestone Pharmaceuticals	35.52%	2.48%	62.00%
Sector	Healthcare Stocks	35.49%	11.75%	52.76%
Industry	Biotech Stocks	34.83%	11.71%	53.46%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	4.97M	9.91%	$6.56M
Rtw investments, lp	6.33M	7.55%	$7.53M
Propel bio management	4.12M	4.91%	$5.08M
Orbimed advisors	3.22M	4.85%	$6.44M
Two sigma investments, lp	2.32M	2.76%	$2.76M
Goldman sachs group	2.00M	2.38%	$2.38M
Marshall wace, llp	1.94M	2.32%	$2.31M
Millennium management	1.54M	1.84%	$1.84M
Simplify asset management	1.51M	1.80%	$1.79M
Point72 asset management	1.09M	1.29%	$1.29M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lion point capital, lp	820.00K	5.83%	$975.80K
Propel bio management	4.12M	3.20%	$5.08M
Amh equity	231.67K	0.58%	$463.34K
Sphera funds management	820.00K	0.35%	$1.64M
Orbimed advisors	3.22M	0.15%	$6.44M
Boxer capital management	666.67K	0.10%	$793.33K
Rtw investments, lp	6.33M	0.07%	$7.53M
Tru independence asset management 2	100.00K	0.07%	$119.00K
October effect	51.95K	0.07%	$61.82K
Simplify asset management	1.51M	0.03%	$1.79M

Top Buyers

Holder	Shares	% Assets	Change
Rtw investments, lp	6.33M	0.07%	3.82M
Orbimed advisors	3.22M	0.15%	3.22M
Goldman sachs group	2.00M	0.00%	2.00M
Millennium management	1.54M	0.00%	1.14M
Balyasny asset management	851.33K	0.00%	851.33K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	-	-	-4.05M
Adage capital partners gp	-	-	-2.81M
Nantahala capital management	-	-	-1.45M
Alta fundamental advisers	-	-	-1.40M
Bml capital management	-	-	-1.14M

New Positions

Holder	Shares	% Assets	Change	Value
Orbimed advisors	3.22M	0.15%	3.22M	$6.44M
Balyasny asset management	851.33K	0.00%	851.33K	$1.01M
Sphera funds management	820.00K	0.35%	820.00K	$1.64M
Amh equity	231.67K	0.58%	231.67K	$463.34K
Boothbay fund management	168.68K	0.00%	168.68K	$200.72K

Sold Out

Holder	Change
Ica group wealth management	-200.00
Srs capital advisors	-1.59K
Jpmorgan chase	-3.27K
Advisor group	-6.00K
Integrated wealth concepts	-10.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	89	3.49%	29,798,338	12.47%	35	2.23%	45	-6.25%	17	88.89%
Dec 31, 2025	42	-36.36%	13,317,824	-60.99%	20	0.76%	26	-39.53%	4	-20.00%
Sep 30, 2025	66	46.67%	34,138,461	213.66%	51	19.08%	43	115.00%	5	-37.50%
Jun 30, 2025	49	4.26%	11,823,806	13.72%	17	7.25%	22	4.76%	9	-18.18%
Mar 31, 2025	48	-4.00%	11,814,084	-51.88%	17	1.30%	21	-12.50%	13	-7.14%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Simplify Propel Opportunities ETF	3.35M	2.85%	-
BlackRock Credit Strategies Instl	231.56K	0.43%	-29.79K
Biotech Growth Ord	147.43K	0.17%	-343.35K
Voya Multi-Manager International Sm Cp A	92.99K	0.11%	92.99K
LUNIS Biotech Growth Opp Fd I a	26.90K	0.05%	-
WEALTHGATE Biotech Fund Inst	26.90K	0.05%	26.90K
Invesco NASDAQ Future Gen 200 ETF	42.80K	0.04%	249.00
Fidelity Nasdaq Composite Index	40.79K	0.03%	-33.23K
SPDR® S&P® International Small Cap ETF	18.73K	0.02%	-
State Street® SPDR® S&P® Intl Sm Cp ETF	22.68K	0.02%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 16, 2026	Oliveto Joseph	President and CEO	Sell	$82.49K
Dec 15, 2025	Bharucha David	Chief Medical Officer	Sell	$134.58K
Jan 26, 2026	Bharucha David	Chief Medical Officer	Sell	$23.63K
Jan 26, 2026	Nelson Jeffrey Edward	Chief Operating Officer	Sell	$23.63K
Dec 15, 2025	Nelson Jeffrey Edward	Chief Operating Officer	Sell	$134.58K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	7
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-

MIST Ownership FAQ

Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals shareholders are primarily institutional investors at 35.52%, followed by 2.48% insiders and 62.00% retail investors. The average institutional ownership in Milestone Pharmaceuticals's industry, Biotech Stocks , is 34.83%, which Milestone Pharmaceuticals exceeds.

Who owns the most shares of Milestone Pharmaceuticals?

Milestone Pharmaceuticals’s largest shareholders are Blackrock (4.97M shares, 9.91%), Rtw investments, lp (6.33M shares, 7.55%), and Propel bio management (4.12M shares, 4.91%). Together, they hold 22.37% of Milestone Pharmaceuticals’s total shares outstanding.

Does Blackrock own Milestone Pharmaceuticals?

Yes, BlackRock owns 9.91% of Milestone Pharmaceuticals, totaling 4.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.56M$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.83% of its assets in 820K Milestone Pharmaceuticals shares, valued at 975.8K$.

Who is the top mutual fund holder of Milestone Pharmaceuticals shares?

Simplify Propel Opportunities ETF is the top mutual fund holder of Milestone Pharmaceuticals shares, with 2.85% of its total shares outstanding invested in 3.35M Milestone Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools